Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australian Mother Threatens Class-Action Against TGA Over Zoloft

This article was originally published in PharmAsia News

Executive Summary

The mother of an Australian girl alleged to have become suicidal after taking Pfizer's Zoloft (sertraline) is considering a suit against the country's drug regulator. The mother settled her $59,000 suit against the physician who prescribed the drug. She said she was contemplating a class-action suit against the Therapeutic Goods Administration on grounds it did not advise the public anti-depressant drugs have risks. The suit against the doctor alleged he falsely promoted Zoloft, the daughter attempted suicide, and the mother had to quit her job to care for the 16 year old. It was discovered the girl had a genetic defect that caused her to have adverse reactions to the sertraline. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts